Review Article

The Efficacy and Safety of Pentoxifylline in the Treatment of Recurrent Aphthous Stomatitis: A Systematic Review

Abstract

Several evidence have shown the beneficial effects of pentoxifylline in the improvement of oral aphthous ulcers. However, the data in this regard are sparse. So, the efficacy and safety of pentoxifylline in oral route was systematically reviewed to elucidate its effects on the size and number of ulcers, as well as the healing time and recurrence frequency in RAS patients. PubMed (Medline), Web of Science, Scopus, ScienceDirect, Cochrane Library, ProQuest, and Clinicaltrial.gov were searched for related articles. The investigated outcomes were pain level, the size and number of ulcers, the frequency of recurrence, the healing time, and finally the pentoxifylline related side effects. Only 6 related study that investigate the efficiency of Pentoxifylline on RAS (n =107) were identified. Decreasing in the pain level, improving the ulcer size and number were establishe in approximately all studies. Pentoxifylline established its ability to shorten the healing time of this type of mouth ulcers. However, its potential to prevent the recurrence of the disease could not established based the data presented here. In conclusion, this systematic review suggests pentoxifylline in RAS patients because it confirmed that RAS patients who received this agent as oral administration reported suitable response. However, conducting more clinical trials with larger sample size and long follow-up time especially to efficiently judge about its ability to the recurrence prevention still is necessary to develop clinical practice guidelines for management of RAS.

1. Setayesh Y, Shirazi AS, Moeintaghavi A. Natural Treatment of Oral Aphthous Ulcers: A Systematic Review. Trans Biomed 2017; 8(4):1-10.
2. Chiang CP, Chang JY, Wang YP, Wu YH, Wu YC, Sun A. Recurrent aphthous stomatitis–Etiology, serum autoantibodies, anemia, hematinic deficiencies, and management. J Formosan Med Assoc 2019;118(9):1279-89.
3. Sharma D, Garg R. A comprehensive review on aphthous stomatitis, its types, management and treatment available. J Dev Drugs 2018;7:1000188.
4. Altenburg A, El-Haj N, Micheli C, Puttkammer M, Abdel-Naser MB, Zouboulis CC. The treatment of chronic recurrent oral aphthous ulcers. Deutsches Ärzteblatt International 2014;111(40):665.
5. Casiglia JM. Recurrent aphthous stomatitis: etiology, diagnosis, and treatment. General Dent 2002;50(2):157-66.
6. Belenguer-Guallar I, Jiménez-Soriano Y, Claramunt-Lozano A. Treatment of recurrent aphthous stomatitis. A literature review. J Clin Experi Dentist 2014;6(2):e168.
7. Eisen D, Lynch DP. Selecting topical and systemic agents for recurrent aphthous stomatitis. Cutis 2001;68(3):201-6.
8. Altenburg A, Zouboulis CC. Current concepts in the treatment of recurrent aphthous stomatitis. Skin Ther Lett 2008;13(7):1-4.
9. Hassan I, Dorjay K, Anwar P. Pentoxifylline and its applications in dermatology. Indian Dermatol Online J 2014;5(4):510.
10. Thornhill MH, Baccaglini L, Theaker E, Pemberton MN. A randomized, double-blind, placebo-controlled trial of pentoxifylline for the treatment of recurrent aphthous stomatitis. Arch Dermatol 2007;143(4):463-70.
11. Mimura MA, Hirota SK, Sugaya NN, Sanches Jr JA, Migliari DA. Systemic treatment in severe cases of recurrent aphthous stomatitis: an open trial. Clinics 2009;64(3):193-8.
12. Slayter KL, Marrie TJ. Treatment of recurrent aphthous ulcers in an HIV patient–An emerging use for pentoxifylline. Can J Inf Dis 1998;9(3):189-90.
13. Wahba-Yahav AV. Pentoxifylline in intractable recurrent aphthous stomatitis: an open trial. J Am Aca Dermatol 1995;33(4):680-2.
14. Pizarro A, Navarro A, Fonseca E, Vidaurrazaga C, Herranz P. Treatment of recurrent aphthous stomatitis with pentoxifylline. Brit J Dermatol 1995;133(4):659-60.
15. Chandrasekhar J, Liem AA, Cox NH, Paterson AW. Oxypentifylline in the management of recurrent aphthous oral ulcersAn open clinical trial. Oral Sur Oral Med Oral Path Oral. Radiol Endodontol 1999;87(5):564-7.
16. Jurge S, Kuffer R, Scully C, Porter SR. Number VI recurrent aphthous stomatitis. Oral Dis 2006;12(1):1-21.
17. Kareem AH, Al-Emaam MK, Jasim ER. Evaluation of Serum B12, Folic Acid, Iron, Ferritin, Total Iron Binding Capacity and Unsaturated Iron Binding Capacity in Patients with Recurrent Aphthous Stomatitis in Sulaimani City. Indian Journal of Public Health Research & Development, 2020;11(5):838–843.
18. Parker R, Armstrong MJ, Corbett C, Rowe IA, Houlihan DD. Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis. Alimentar Pharmacol Ther 2013;37(9):845-54.
19. Revuz J, Guillaume JC, Janier M, et al. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis. Arch Dermatol 1990;126(7):923-7.
20. Grinspan D, Blanco GF, Agüero S. Treatment of aphthae with thalidomide. J Am Aca Dermatol 1989;20(6):1060-3.
21. Bonnetblanc JM, Royer C, Bedane C. Thalidomide and recurrent aphthous stomatitis: a follow-up study. Dermatol 1996;193(4):321-3.
22. Altinor S, Öztürkcan S, Hah MM. The effects of colchicine on neutrophil function in subjects with recurrent aphthous stomatitis. J Eur Aca Dermatol Venereol 2003;17(4):469-70.
23. Niel E, Scherrmann JM. Colchicine today. Joint Bone Spine 2006;73(6):672-8.
Files
IssueVol 10, No 1 (Winter 2022) QRcode
SectionReview Article(s)
DOI https://doi.org/10.18502/jpc.v10i1.9127
Keywords
Aphthous Stomatitis Pentoxifylline Systematic Review
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Eshghinejad A, Panahandeh E, Memarfar M, Soltani R, Shafiee F. The Efficacy and Safety of Pentoxifylline in the Treatment of Recurrent Aphthous Stomatitis: A Systematic Review. J Pharm Care. 2022;10(1):34-39.